The Venture Codex Logo

The Venture Codex

Multiple Myeloma Research Foundation

383 Main Avenue, 7th Floor, Norwalk, CT, 06851, United States

Overview

Non-profit organization focused on cancer treatment research.

Founded

1998

Deals ยท 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Seed
Series A

Geographic focus

Canada
United States

Sector focus

Charity
Health Care
Non Profit

Investment portfolio

2rounds
NAMEDATESIZE
Reverb Therapeutics
Feb 2025Participated
$12 MSeed
Trio Pharmaceuticals
Dec 2024Participated
$3 MSeries A
Reverb Therapeutics
Feb 2025Participated
$12 MSeed
Trio Pharmaceuticals
Dec 2024Participated
$3 MSeries A
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Multiple Myeloma Research Foundation: 2 funding rounds are recorded in the selected participation categories.All available history.
Multiple Myeloma Research Foundation: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A01

Monthly Deal Activity

Multiple Myeloma Research Foundation: 2 deals are recorded across 23 months.All available history.
Multiple Myeloma Research Foundation: 2 deals are recorded across 23 months. All available history
MonthDeals
Dec '241
Jan '250
Feb '251
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Multiple Myeloma Research Foundation: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Multiple Myeloma Research Foundation: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2

Deal Size Distribution

Multiple Myeloma Research Foundation: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Multiple Myeloma Research Foundation: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Multiple Myeloma Research Foundation: Canada has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Multiple Myeloma Research Foundation: Canada has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
Canada1
United States1
Multiple Myeloma Research Foundation: 9 co-investors are shown, with Amplitude Ventures sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Multiple Myeloma Research Foundation: 9 co-investors are shown, with Amplitude Ventures sharing 1 recorded deals. All available history
Co-investorShared deals
Amplitude Ventures1
Finchley Healthcare Ventures1
Friedman BioVentures1
InBC Investment1
KdT Ventures1
Life Science Angels1
Myeloma Investment Fund1
NuFund Venture Group1
Seido Capital1

Investment Strategy

Multiple Myeloma Research Foundation: Led accounts for 0% and participating for 100% of round participation.All available history.
Multiple Myeloma Research Foundation: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating2100%
Multiple Myeloma Research Foundation: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Multiple Myeloma Research Foundation: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

George Mulligan

Chief Scientific Officer

Karen Andrews, Esq.

Board Member

Vanessa V. Bottazzi

Director, Human Resources

W Dana LaForge

Director, former Chairman of the Board